PreppinPeppers › Facts › Lab article
Liraglutide: Reference Overview and Reconstitution Notes
Machine-readable facts for this Lab article. The full page is https://www.preppinpeppers.com/blogs/the-lab/liraglutide.
TL;DR
Liraglutide is an acylated GLP-1 receptor agonist peptide of about 31 amino acids in the metabolic and weight-regulation category. Reconstitution notes.
Facts Index
| Fact ID | Category | Entity | Attribute | Value | Source |
|---|---|---|---|---|---|
| liraglutide:title | identity | Liraglutide: Reference Overview and Reconstitution Notes | title | Liraglutide: Reference Overview and Reconstitution Notes | Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide) (evidence) |
| liraglutide:published | identity | Liraglutide: Reference Overview and Reconstitution Notes | published | 2026-08-15 | Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide) (evidence) |
| liraglutide:author | identity | Liraglutide: Reference Overview and Reconstitution Notes | author | Preppin' Peppers Editorial Team | Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide) (evidence) |
| liraglutide:topics | identity | Liraglutide: Reference Overview and Reconstitution Notes | topics | FDA-approved or specific-use, research | Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide) (evidence) |
| liraglutide:summary | content | Liraglutide: Reference Overview and Reconstitution Notes | summary | Liraglutide is an acylated GLP-1 receptor agonist peptide of about 31 amino acids in the metabolic and weight-regulation category. Reconstitution notes. | Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide) (evidence) |
| liraglutide:section-1 | content | Liraglutide: Reference Overview and Reconstitution Notes | section | What it is | Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide) (evidence) |
| liraglutide:section-2 | content | Liraglutide: Reference Overview and Reconstitution Notes | section | Liraglutide | Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide) (evidence) |
| liraglutide:section-3 | content | Liraglutide: Reference Overview and Reconstitution Notes | section | What it is | Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide) (evidence) |
| liraglutide:section-4 | content | Liraglutide: Reference Overview and Reconstitution Notes | section | Research context and categorization | Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide) (evidence) |
| liraglutide:section-5 | content | Liraglutide: Reference Overview and Reconstitution Notes | section | Status | Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide) (evidence) |
| liraglutide:section-6 | content | Liraglutide: Reference Overview and Reconstitution Notes | section | Reconstitution notes (general) | Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide) (evidence) |
| liraglutide:section-7 | content | Liraglutide: Reference Overview and Reconstitution Notes | section | Dilution and handling notes (compound-specific) | Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide) (evidence) |
| liraglutide:section-8 | content | Liraglutide: Reference Overview and Reconstitution Notes | section | Handling and storage | Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide) (evidence) |
| liraglutide:section-9 | content | Liraglutide: Reference Overview and Reconstitution Notes | section | Related reading | Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide) (evidence) |
| liraglutide:section-10 | content | Liraglutide: Reference Overview and Reconstitution Notes | section | Tools and supplies | Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide) (evidence) |
| liraglutide:section-12 | content | Liraglutide: Reference Overview and Reconstitution Notes | section | What the research community gets wrong about liraglutide handling | Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide) (evidence) |
| liraglutide:product-gansulin-metal-peptide-pen | products | Liraglutide: Reference Overview and Reconstitution Notes | references product | Gansulin Pen ยท Reusable Click-Dial, 3 ml (1-60 Units) | Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide) (evidence) |
| liraglutide:product-gansulin-3ml-cartridge | products | Liraglutide: Reference Overview and Reconstitution Notes | references product | Gansulin-Compatible 3 ml Glass Cartridge for Pens (10-Pack) | Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide) (evidence) |
| liraglutide:source-pubchem-ncbi-nlm-nih-gov | source | Liraglutide: Reference Overview and Reconstitution Notes | cites | NCBI PubChem CID 16134956: Liraglutide (C172H265N43O51) - pubchem.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide) (evidence) |
| liraglutide:source-dailymed-nlm-nih-gov | source | Liraglutide: Reference Overview and Reconstitution Notes | cites | VICTOZA (liraglutide) injection label , FDA/DailyMed (solution pH ~8.15, phosphate buffer, store 2-8 C, do not freeze) - dailymed.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide) (evidence) |
| liraglutide:source-pubmed-ncbi-nlm-nih-gov | source | Liraglutide: Reference Overview and Reconstitution Notes | cites | Frederiksen et al., Biophys J 2015: Oligomerization of a Glucagon-like Peptide 1 Analog: Bridging Experiment and Simulations - pubmed.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide) (evidence) |
| liraglutide:source-pmc-ncbi-nlm-nih-gov | source | Liraglutide: Reference Overview and Reconstitution Notes | cites | Knudsen and Lau, Front Endocrinol (Lausanne) 2019: The Discovery and Development of Liraglutide and Semaglutide - pmc.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide) (evidence) |
| liraglutide:source-pmc-ncbi-nlm-nih-gov-2 | source | Liraglutide: Reference Overview and Reconstitution Notes | cites | Tobaiqy and Elkout, Int J Clin Pharm 2024: Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database - pmc.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide) (evidence) |
| liraglutide:source-pmc-ncbi-nlm-nih-gov-3 | source | Liraglutide: Reference Overview and Reconstitution Notes | cites | Anirban et al., Indian J Endocrinol Metab 2018: Liraglutide - Indian Experience - pmc.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide) (evidence) |
FAQ
- What is the molecular weight and structure of liraglutide?
- Liraglutide is a ~31-amino-acid peptide with a molecular weight of approximately 3,751 Da. A palmitoyl fatty-acid tail is attached to its side chain, allowing loose binding to albumin, which slows enzymatic breakdown and extends molecular stability.
- How is research-grade liraglutide reconstituted?
- Research-grade liraglutide arrives as lyophilized (freeze-dried) powder. It is reconstituted by adding bacteriostatic water; the resulting concentration equals milligrams of powder divided by milliliters of water added (mg/mL).
- Is liraglutide prohibited by WADA for competitive athletes?
- Liraglutide is not currently named as a prohibited substance on the WADA Prohibited List. The list is updated annually and some GLP-1 class compounds appear on the WADA Monitoring Program, so competitors should verify the current list directly.